Ars Pharmaceuticals Share Price Today
(NASDAQ: SPRY)

Name: Ars Pharmaceuticals Share Price Today (NASDAQ: SPRY) - Ars Pharmaceuticals Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Ars Pharmaceuticals share price is $14.88 & ₹1,271.72 as on 18 Apr 2025, 2.30 'hrs' IST

$14.88

Market is closed - opens 7 PM, 21 Apr 2025

View live Ars Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Ars Pharmaceuticals stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Ars Pharmaceuticals, along with analyst recommendations, forecasts, and comprehensive financials.

Ars Pharmaceuticals share price movements

Today's Low: $14.46
Today's High: $15.07
$14.88
2.82%
Downside
Day's Volatility :4.05%
Upside
1.26%
52 Weeks Low: $7.55
52 Weeks High: $18.51
$14.88
49.26%
Downside
52 Weeks Volatility :59.21%
Upside
19.61%

Ars Pharmaceuticals (SPRY) Returns

Period	Ars Pharmaceuticals Inc	Index (Russel 2000)
3 Months	10.39%	0.0%
6 Months	-11.0%	0.0%
1 Year	75.68%	0.0%
3 Years	372.38%	-12.9%

Ars Pharmaceuticals (SPRY) Key Statistics

in dollars & INR

Previous Close	$14.88
Open	$14.79
Today's High	$15.07
Today's Low	$14.46
Market Capitalization	$1.5B
Today's Volume	$1.6M
52 Week High	$18.51
52 Week Low	$7.55
Revenue TTM	$89.1M
EBITDA	$-3.0M
Earnings Per Share (EPS)	$0.08
PE Ratio	186.0
Profit Margin	8.97%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	3.28%

How to invest in Ars Pharmaceuticals Stock (SPRY) from India?

It is very easy for Indian residents to invest directly in Ars Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Ars Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Ars Pharmaceuticals or SPRY on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Ars Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Ars Pharmaceuticals shares which would translate to 0.057 fractional shares of Ars Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Ars Pharmaceuticals, in just a few clicks!

Returns in Ars Pharmaceuticals (SPRY) for Indian investors in Rupees

The Ars Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Ars Pharmaceuticals investment value today

Current value as on today

₹1,78,020

Returns

₹78,020

(+78.02%)

Returns from Ars Pharmaceuticals Stock

₹75,679 (+75.68%)

Dollar Returns

₹2,341 (+2.34%)

Indian investors sentiment towards Ars Pharmaceuticals (SPRY)

-25%

Period: Mar 19, 2025 to Apr 18, 2025. Change in 30 Days versus previous period

Search interest for Ars Pharmaceuticals Stock from India on INDmoney has decreased by -25% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Ars Pharmaceuticals

RA Capital Management, LLC
11.07%
Deerfield Management Co
10.72%
Orbimed Advisors, LLC
8.45%
BlackRock Inc
4.66%
SR ONE CAPITAL MANAGEMENT, LP
4.09%
AllianceBernstein L.P.
3.96%

Analyst Recommendation on Ars Pharmaceuticals

Rating

Trend

Buy

88%Buy

11%Hold

0%Sell

Based on 9 Wall street analysts offering stock ratings for Ars Pharmaceuticals(by analysts ranked 0 to 5 stars)

Analyst Forecast on Ars Pharmaceuticals Stock (SPRY)

What analysts predicted

Upside of 112.37%

Target:

$31.60

Current:

$14.88

Insights on Ars Pharmaceuticals Stock (Ticker Symbol: SPRY)

Price Movement
In the last 1 month, SPRY stock has moved up by 27.7%
Increasing Revenue
Revenue is up for the last 4 quarters, -30.0K → 86.58M (in $), with an average increase of 93.1% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -19.12M → 49.93M (in $), with an average increase of 138.3% per quarter
SPRY vs ONC (1 yr)
In the last 1 year, Beone Medicines Ltd has given 76.1% return, outperforming this stock by 0.4%
Price to Sales
ForSPRY every $1 of sales, investors are willing to pay $16.2, whereas for Beone Medicines Ltd, the investors are paying $6.4 for every $1 of sales.

Ars Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Ars Pharmaceuticals is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Ars Pharmaceuticals (SPRY) Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Ars Pharmaceuticals Inc	3.98%	-11.0%	75.68%	372.38%	-40.48%
Regeneron Pharmaceuticals, Inc.	-17.1%	-41.85%	-37.2%	-21.74%	-0.85%
Beone Medicines Ltd	-13.12%	5.03%	78.34%	40.23%	43.44%
Vertex Pharmaceuticals Incorporated	-4.76%	2.3%	24.05%	71.43%	78.99%
Alnylam Pharmaceuticals, Inc.	-9.09%	-19.67%	62.43%	39.66%	61.91%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Ars Pharmaceuticals Inc	186.0	186.0	NA	-1.43	0.03	-0.01	NA	2.62
Regeneron Pharmaceuticals, Inc.	14.68	14.68	0.9	41.18	0.16	0.07	0.01	273.57
Beone Medicines Ltd	NA	NA	NA	1.09	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.34	17.96	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.81	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Ars Pharmaceuticals Inc	Buy	$1.5B	-40.48%	186.0	8.97%
Regeneron Pharmaceuticals, Inc.	Buy	$60.5B	-0.85%	14.68	31.07%
Beone Medicines Ltd	NA	$26.9B	43.44%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$125.7B	78.99%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$30.4B	61.91%	NA	-12.37%

About Ars Pharmaceuticals

ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes treatments for severe allergic reactions. The company is involved in the development of neffy, a needle-free and low-dose intranasal epinephrine nasal spray for rescue medication for people with Type I severe allergic reactions, including anaphylaxis. It serves healthcare professionals, patients, and caregivers. The company was founded in 2015 and is headquartered in San Diego, California.

Organization	Ars Pharmaceuticals
Employees	155
CEO	Mr. Richard Lowenthal M.B.A., M.S., MSMSEL
Industry	Healthcare

Management People of Ars Pharmaceuticals

Name	Title
Mr. Richard Lowenthal M.B.A., M.S., MSMSEL	Co-Founder, President, CEO & Director
Dr. Sarina Tanimoto M.B.A., M.D.	Co-Founder & Chief Medical Officer
Mr. Alexander A. Fitzpatrick Esq.	Chief Legal Officer & Secretary
Dr. Robert Bell Ph.D.	Co-Founder & Chief Science Officer
Ms. Kathleen D. Scott CPA	Chief Financial Officer
Mr. Brian T. Dorsey M.S.	Chief Operations Officer
Mr. Daniel Relovsky	Senior Vice President of Marketing
Mr. Harris Kaplan M.B.A.	Executive Vice President of Commercial Strategy
Mr. Eric Karas	Chief Commercial Officer
Mr. Justin Chakma	Chief Business Officer & Secretary

Important FAQs about investing in SPRY Stock from India :

What is Ars Pharmaceuticals share price today?

Ars Pharmaceuticals share price today stands at $14.88, Open: $14.79 ; Previous Close: $14.88 ; High: $15.07 ; Low: $14.46 ; 52 Week High: $18.51 ; 52 Week Low: $7.55.

The stock opens at $14.79, after a previous close of $14.88. The stock reached a daily high of $15.07 and a low of $14.46, with a 52-week high of $18.51 and a 52-week low of $7.55.

Can Indians buy Ars Pharmaceuticals shares?

Yes, Indians can invest in the Ars Pharmaceuticals (SPRY) from India.

With INDmoney, you can buy Ars Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Ars Pharmaceuticals at zero transaction cost.

How can I buy Ars Pharmaceuticals shares from India?

It is very easy to buy Ars Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Ars Pharmaceuticals (SPRY) be purchased?

Yes, you can buy fractional shares of Ars Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Ars Pharmaceuticals stocks?

To start investing in Ars Pharmaceuticals, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.